MRKR Buybacks
3 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–3; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Marker Therapeutics, Inc. | 2018-12-31 | Reported repurchase cash | $71,710.00 |
| Marker Therapeutics, Inc. | 2017-12-31 | Reported repurchase cash | $0.00 |
| Marker Therapeutics, Inc. | 2016-12-31 | Reported repurchase cash | $0.00 |